Postnatal blocking of interferon-γ function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice

Mitsuhisa Koga, Hisashi Kai, Hideo Yasukawa, Seiya Kato, Tomoka Yamamoto, Yumiko Kawai, Ken Kusaba, Yukihiko Seki, Mamiko Kai, Kensuke Egashira, Yusufumi Kataoka, Tsutomu Imaizumi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

It is unknown whether interferon-γ has a positive or negative impact on atherosclerotic plaque formation. Thus, we examined the effects of postnatal interferon-γ function blocking on plaque formation in apolipoprotein E-knockout (apoEKO) mice by overexpressing a soluble mutant of interferon-γ receptor (sIFNγR), an interferon-γ inhibitory protein. Mice were fed a Western-type diet from 8 weeks of age. sIFNγR or mock plasmid (control) was injected into the thigh muscle at 8 and 10 weeks' age, because serum sIFNγR protein was transiently increased with a peak at 2 days after a single sIFNγR gene transfer and remained elevated for 2 weeks. At 12 weeks' age, control apoEKO mice showed marked atherosclerotic plaques from the ascending aorta to the aortic arch. The plaques in the aortic root had massive lipid cores and macrophage infiltration with thin fibrous cap and few smooth muscle cells, demonstrating low plaque stability. In contrast, the luminal plaque area was remarkably reduced in sIFNγR-treated apoEKO mice. sIFNγR treatment not only reduced lipid core areas and macrophage infiltration but also increased smooth muscle cell count and fibrotic area, suggesting improved plaque stability. In controls, interieukin-1β, monocyte chemoattractant protein-1, and vascular cell adhesion molecules-1 were remarkably upregulated in the aortic wall. These changes were significantly reversed by sIFNγR. sIFNγR treatment had no effects on serum cholesterol levels. In conclusion, sIFNγR treatment prevented plaque formation in apoEKO mice by inhibiting inflammatory changes in the arterial wall. The present study provides insight into a new strategy for preventing atherosclerosis.

Original languageEnglish
Pages (from-to)259-267
Number of pages9
JournalHypertension Research
Volume30
Issue number3
DOIs
Publication statusPublished - Mar 1 2007

Fingerprint

Interferon Receptors
Apolipoproteins E
Atherosclerotic Plaques
Knockout Mice
Interferons
Smooth Muscle Myocytes
Macrophages
Lipids
Vascular Cell Adhesion Molecule-1
Chemokine CCL2
Thigh
Serum
Thoracic Aorta
Aorta
Atherosclerosis
Proteins
Plasmids
Cell Count
Cholesterol

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Postnatal blocking of interferon-γ function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. / Koga, Mitsuhisa; Kai, Hisashi; Yasukawa, Hideo; Kato, Seiya; Yamamoto, Tomoka; Kawai, Yumiko; Kusaba, Ken; Seki, Yukihiko; Kai, Mamiko; Egashira, Kensuke; Kataoka, Yusufumi; Imaizumi, Tsutomu.

In: Hypertension Research, Vol. 30, No. 3, 01.03.2007, p. 259-267.

Research output: Contribution to journalArticle

Koga, M, Kai, H, Yasukawa, H, Kato, S, Yamamoto, T, Kawai, Y, Kusaba, K, Seki, Y, Kai, M, Egashira, K, Kataoka, Y & Imaizumi, T 2007, 'Postnatal blocking of interferon-γ function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice', Hypertension Research, vol. 30, no. 3, pp. 259-267. https://doi.org/10.1291/hypres.30.259
Koga, Mitsuhisa ; Kai, Hisashi ; Yasukawa, Hideo ; Kato, Seiya ; Yamamoto, Tomoka ; Kawai, Yumiko ; Kusaba, Ken ; Seki, Yukihiko ; Kai, Mamiko ; Egashira, Kensuke ; Kataoka, Yusufumi ; Imaizumi, Tsutomu. / Postnatal blocking of interferon-γ function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. In: Hypertension Research. 2007 ; Vol. 30, No. 3. pp. 259-267.
@article{dbc2226a51df43a58ec590da31088447,
title = "Postnatal blocking of interferon-γ function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice",
abstract = "It is unknown whether interferon-γ has a positive or negative impact on atherosclerotic plaque formation. Thus, we examined the effects of postnatal interferon-γ function blocking on plaque formation in apolipoprotein E-knockout (apoEKO) mice by overexpressing a soluble mutant of interferon-γ receptor (sIFNγR), an interferon-γ inhibitory protein. Mice were fed a Western-type diet from 8 weeks of age. sIFNγR or mock plasmid (control) was injected into the thigh muscle at 8 and 10 weeks' age, because serum sIFNγR protein was transiently increased with a peak at 2 days after a single sIFNγR gene transfer and remained elevated for 2 weeks. At 12 weeks' age, control apoEKO mice showed marked atherosclerotic plaques from the ascending aorta to the aortic arch. The plaques in the aortic root had massive lipid cores and macrophage infiltration with thin fibrous cap and few smooth muscle cells, demonstrating low plaque stability. In contrast, the luminal plaque area was remarkably reduced in sIFNγR-treated apoEKO mice. sIFNγR treatment not only reduced lipid core areas and macrophage infiltration but also increased smooth muscle cell count and fibrotic area, suggesting improved plaque stability. In controls, interieukin-1β, monocyte chemoattractant protein-1, and vascular cell adhesion molecules-1 were remarkably upregulated in the aortic wall. These changes were significantly reversed by sIFNγR. sIFNγR treatment had no effects on serum cholesterol levels. In conclusion, sIFNγR treatment prevented plaque formation in apoEKO mice by inhibiting inflammatory changes in the arterial wall. The present study provides insight into a new strategy for preventing atherosclerosis.",
author = "Mitsuhisa Koga and Hisashi Kai and Hideo Yasukawa and Seiya Kato and Tomoka Yamamoto and Yumiko Kawai and Ken Kusaba and Yukihiko Seki and Mamiko Kai and Kensuke Egashira and Yusufumi Kataoka and Tsutomu Imaizumi",
year = "2007",
month = "3",
day = "1",
doi = "10.1291/hypres.30.259",
language = "English",
volume = "30",
pages = "259--267",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Postnatal blocking of interferon-γ function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice

AU - Koga, Mitsuhisa

AU - Kai, Hisashi

AU - Yasukawa, Hideo

AU - Kato, Seiya

AU - Yamamoto, Tomoka

AU - Kawai, Yumiko

AU - Kusaba, Ken

AU - Seki, Yukihiko

AU - Kai, Mamiko

AU - Egashira, Kensuke

AU - Kataoka, Yusufumi

AU - Imaizumi, Tsutomu

PY - 2007/3/1

Y1 - 2007/3/1

N2 - It is unknown whether interferon-γ has a positive or negative impact on atherosclerotic plaque formation. Thus, we examined the effects of postnatal interferon-γ function blocking on plaque formation in apolipoprotein E-knockout (apoEKO) mice by overexpressing a soluble mutant of interferon-γ receptor (sIFNγR), an interferon-γ inhibitory protein. Mice were fed a Western-type diet from 8 weeks of age. sIFNγR or mock plasmid (control) was injected into the thigh muscle at 8 and 10 weeks' age, because serum sIFNγR protein was transiently increased with a peak at 2 days after a single sIFNγR gene transfer and remained elevated for 2 weeks. At 12 weeks' age, control apoEKO mice showed marked atherosclerotic plaques from the ascending aorta to the aortic arch. The plaques in the aortic root had massive lipid cores and macrophage infiltration with thin fibrous cap and few smooth muscle cells, demonstrating low plaque stability. In contrast, the luminal plaque area was remarkably reduced in sIFNγR-treated apoEKO mice. sIFNγR treatment not only reduced lipid core areas and macrophage infiltration but also increased smooth muscle cell count and fibrotic area, suggesting improved plaque stability. In controls, interieukin-1β, monocyte chemoattractant protein-1, and vascular cell adhesion molecules-1 were remarkably upregulated in the aortic wall. These changes were significantly reversed by sIFNγR. sIFNγR treatment had no effects on serum cholesterol levels. In conclusion, sIFNγR treatment prevented plaque formation in apoEKO mice by inhibiting inflammatory changes in the arterial wall. The present study provides insight into a new strategy for preventing atherosclerosis.

AB - It is unknown whether interferon-γ has a positive or negative impact on atherosclerotic plaque formation. Thus, we examined the effects of postnatal interferon-γ function blocking on plaque formation in apolipoprotein E-knockout (apoEKO) mice by overexpressing a soluble mutant of interferon-γ receptor (sIFNγR), an interferon-γ inhibitory protein. Mice were fed a Western-type diet from 8 weeks of age. sIFNγR or mock plasmid (control) was injected into the thigh muscle at 8 and 10 weeks' age, because serum sIFNγR protein was transiently increased with a peak at 2 days after a single sIFNγR gene transfer and remained elevated for 2 weeks. At 12 weeks' age, control apoEKO mice showed marked atherosclerotic plaques from the ascending aorta to the aortic arch. The plaques in the aortic root had massive lipid cores and macrophage infiltration with thin fibrous cap and few smooth muscle cells, demonstrating low plaque stability. In contrast, the luminal plaque area was remarkably reduced in sIFNγR-treated apoEKO mice. sIFNγR treatment not only reduced lipid core areas and macrophage infiltration but also increased smooth muscle cell count and fibrotic area, suggesting improved plaque stability. In controls, interieukin-1β, monocyte chemoattractant protein-1, and vascular cell adhesion molecules-1 were remarkably upregulated in the aortic wall. These changes were significantly reversed by sIFNγR. sIFNγR treatment had no effects on serum cholesterol levels. In conclusion, sIFNγR treatment prevented plaque formation in apoEKO mice by inhibiting inflammatory changes in the arterial wall. The present study provides insight into a new strategy for preventing atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=34247234578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247234578&partnerID=8YFLogxK

U2 - 10.1291/hypres.30.259

DO - 10.1291/hypres.30.259

M3 - Article

C2 - 17510508

AN - SCOPUS:34247234578

VL - 30

SP - 259

EP - 267

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 3

ER -